Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone

INTRODUCTION: Twenty-five percent of stage II colon cancer (CC) patients relapse within 5 years due to minimal residual disease (MRD) not eliminated by surgery. We hypothesise that subtypes of MRD, defined by circulating tumour cells (CTCs) and bone marrow micrometastasis (mM), have different types...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ecancermedicalscience
Main Authors: Murray, Nigel P, Aedo, Socrates, Villalon, Ricardo, Albarran, Vidal, Orrego, Shenda, Guzman, Eghon
Formato: Artigo
Idioma:Inglês
Publicado em: Cancer Intelligence 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7652547/
https://ncbi.nlm.nih.gov/pubmed/33209110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2020.1119
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados